Article Information
History
- August 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chioma Izzi-Engbeayaa,1,2,3,
- Walter Distasoa,4,
- Anjali Amin1,2,
- Wei Yang2,5,
- Oluwagbemiga Idowu1,2,
- Julia S Kenkre2,5,
- Ronak J Shah1,
- Evelina Woin1,
- Christine Shi1,
- Nael Alavi1,2,
- Hala Bedri1,
- Niamh Brady1,
- Sophie Blackburn1,2,
- Martina Leczycka1,2,
- Sanya Patel1,2,
- Elizaveta Sokol1,2,
- Edward Toke-Bjolgerud1,2,
- Ambreen Qayum1,2,
- Mariana Abdel-Malek2,5,
- David C D Hope1,2,3,
- Nick S Oliver1,2,3,
- Vasiliki Bravis1,2,
- Shivani Misra1,2,3,
- Tricia M Tan1,2,3,5,
- Neil Hillb,1,2,3 and
- Victoria Salem*,b,1,2,3
- 1Division of Medicine and Integrated Care, Imperial College Healthcare NHS Trust, London, UK
- 2Imperial Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, UK
- 3Section of Investigative Medicine and Endocrinology, Department of Metabolism, Digestion and Reproduction, Imperial College London, UK
- 4Imperial College London Business School, London, UK
- 5Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
- ↵*Correspondence to:
Dr Victoria Salem, Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, W12 0NN, UK. +44 (0)20 7594 2489 v.salem{at}imperial.ac.uk
↵a Joint first authors;
b Joint senior authors
Posted August 11, 2020.
Severe COVID-19 and Diabetes - A Retrospective Cohort Study from Three London Teaching Hospitals
